This is an aggregated industry headline. Read the full story at Drug Channels →
The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground (rerun)
This week, we're rerunning some popular posts while we prepare for tomorrow's live video webinar: 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders. Click here to see the original post from April 2026. By Adam J. Fein, Ph.D.Drug Channels Institute's (DCI's) latest anal
By Drug Channels
· Jun 11, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
After a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the Sanofi subsidia…
The WeekFierceBiotech ↗
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx…
The WeekBriefing
The FDA has granted premarket approval to United Therapeutics' LungFX device, designed to assess donor lungs f…